diabetes, fasting and restricted diets were used to treat this disease. The discovery of insulin in the 1920s was one of the most significant medical breakthroughs in the treatment of diabetes. Prior to the discovery of insulin, the life expectancy for children and adults with diabetes was very...
Undertreatment or over treatment of a thyroid problem can lead to a myriad of problems, including heart conditions. Are generic drugs equal to “branded” ones? Levothyroxine has a narrow therapeutic window meaning the range between a proper dose and a toxic one is narrow. Am I getting the pr...
The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTA
And that's why patients on the conventional treatment for type 2 diabetes do not get better, they get worse with more and more severe complications down the road. When you understand the actual disease, you can see why taking insulin and other medications that increase insulin is the worst ...
Educational programmes provide a priority to combat degenerative diseases in the medium term; however, many graduates have the knowledge but lack the skills to promote an effective treatment. As a result, clinical inertia is a major contributor to the inefficiency of the system. Finally, public ...
In humans with type 2 diabetes, 3 months of anakinra treatment increased insulin secretion and decreased the ratio of proinsulin to insulin [74], indicating improved beta cell function. Interestingly, the ratio remained improved for 39 weeks after anakinra withdrawal [90]. However, longer studies ...
Treatment Outcomes of Type 2 diabetes : Do the Achievements Differ by Age, Sex, or Comorbidity? (Nazma Nazu: Treatment Outcomes of Type 2 Diabetes)... Biomedicum, Helsinki 29.5 Miles from Porvoo Type 2 diabetes (T2D) is a major public health problem. The main concern of T2D is the inc...
Methods: We retrospectively analyzed data from a double-blind, randomized, multi-center, international clinical trial of culture-confirmed MRSA NP that compared treatment with linezolid to vancomycin. Specifically, we evaluated the clinical and microbiologic outcomes of patients with and without diabetes ...
The presence of T2D with concomitant PAD is related to an increased risk of both all-cause and cardiovascular mortality compared with individuals with only PAD. This argues for implementing optimized and intensive treatment strategies for individuals with both conditions.Back...
WO/2003/004496 January, 2003 DPP-IV-INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES WO/2003/024965 March, 2003 HETEROCYCLIC COMPOUNDS THAT ARE INHIBITORS OF THE ENZYME DPP-IV WO/2003/033686 April, 2003 KERATINOCYTES WHICH MAY BE USED AS BIOLOGICALLY ACTIVE SUBSTANCES FOR THE TREATMENT ...